{"schema_version":"secwatch.filing_event.v1","accession":"0000055529-23-000003","form_type":"8-K","ticker":"KEQU","cik":"0000055529","company_name":"KEWAUNEE SCIENTIFIC CORP /DE/","filed_at":"2023-03-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.741501+00:00","generated_at":"2026-06-18T09:00:48.553468+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Kewaunee Q3 net income $723K ($0.25 EPS) vs loss; sales up 49.7%","bullets":["Net earnings $723K ($0.25 diluted EPS) vs net loss $1,319K (-$0.47); sales $60.8M, +49.7% YoY.","Domestic segment sales $36.1M (+22.4%), net income $417K vs prior year loss of $305K.","International segment sales $24.7M (+122.4%), net income $1.56M vs $573K; backlog $153.2M.","Awarded multi-year contract to supply lab products to Indian Oil Corporation Limited.","Cash $18.4M vs $6.9M; debt-to-equity 1.22:1; short-term debt $5.8M, long-term debt $29.2M."],"urls":{"canonical":"https://secwatch.observer/filing/0000055529-23-000003","json":"https://secwatch.observer/filing/0000055529-23-000003.json","markdown":"https://secwatch.observer/filing/0000055529-23-000003.md","text":"https://secwatch.observer/filing/0000055529-23-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/55529/000005552923000003/0000055529-23-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/55529/000005552923000003/kequ-20230308.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T09:00:48.553468+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}